In septic shock, hypotension, disseminated intravascular coagulation, and neutrophil activation are related to the activation of the blood coagulation contact system. This study evaluates in dogs the effect of the Cl-esterase inhibitor (C1-INH), a main inhibitor of the blood coagulation contact system, on the cardiovascular and respiratory dysfunction associated with endotoxic shock. Two groups were included: controls, which received Escherichia coli endotoxin, and a C1-INH group in which Cl-INH was infused before E. coli endotoxin administration.
Introduction
Gram-negative bacteriemia produces multiorgan dysfunction, septic shock, and frequently death (1) (2) (3) (4) (5) (6) (7) . The pathogenic factors and mechanisms involved in septic shock are still unclear.
Endotoxin may directly impair the cardiac function. Several authors have observed that the intravenous administration of endotoxin produces a deterioration of cardiac function; this negative effect is independent of cardiac filling pressure and systemic vascular resistance (8) (9) (10) (11) (12) .
Endotoxemia increases plasma protease activity ( 13-17) and promotes the activation ofthe blood contact system contributing to disseminated intravascular coagulation, hypotension, and neutrophil activation ( 18) . It appears that endotoxin activates the coagulation through both a direct effect and by influencing endothelial cell function (19) (20) (21) (22) . Pulmonary dysfunction due to acute respiratory distress syndrome (ARDS) I occurs in 25-40% of patients with endotoxemia (23, 24) . Microscopic examination of lung tissues from ARDS patients shows damage in both alveolar epithelial cells and capillary endothelium. This is accompanied by a hemorrhagic intraalveolar exudate high in platelets, fibrin clotting factors, and plasminogen (25, 26) . Recently, Idell et al. (27) have documented that both tissue factor VII procoagulant activity and extrinsic pathway inhibitor activity were increased in bronchoalveolar lavage of ARDS patients. In addition, Bertozzi et al. (28) have shown an increase in antifibrinolytic activity in the bronchoalveolar lavage ofpatients with ARDS. These studies suggest that an alteration in blood coagulation and fibrinolysis may play a role in the pathogenesis of ARDS induced by endotoxemia.
In a previous report, we observed decreased plasma levels of prekallikrein (PK) in patients with ARDS (29) ; this finding was considered a result ofthe activation ofthe contact phase of blood coagulation (29, 30) . In these patients, the decrease in plasma PK levels correlated with the degree ofpulmonary dysfunction. By contrast, plasma PK levels were unchanged in patients with cardiogenic pulmonary edema which is not associated with structural pulmonary damage (31 ) . Taken together these results suggest that an activation ofthe blood coagulation contact system could be a factor in the pathogenesis of endotoxin-induced ARDS. C 1-esterase inhibitor (C 1-INH) is the main inhibitor ofthe blood coagulation contact system (32, 33) . In that hypotension, disseminated intravascular coagulation and neutrophil activation are consequences of activation of the contact system, its inhibition by administration of Cl-INH may help to prevent endotoxin-induced organ dysfunction (22, 34, 35 The aim ofthis study was to evaluate the effect ofinhibition of the blood coagulation contact system on the cardiovascular and respiratory function in an animal model of endotoxic shock.
Methods
Animal model. The study was performed in mongrel dogs (22-32 kg) . During the 24-h period before the experiment, the dogs were allowed access to water but not food. 1 h before the initiation of the study, the dogs received droperidol (2.5 mg) and fentanyl (0.05 mg) intramuscularly. Anesthesia was induced by i.v. administration of sodium pentobarbital ( 15 mg/kg of body weight), pancuronium bromide (0.1 mg/ kg of body weight), and fentanyl (0.05 mg/kg of body weight). An endotracheal tube was placed and ventilation was maintained using a volumetric respirator (Pulmelec, Manofacturas Medicas, Madrid, Spain). The ventilatory parameters were: tidal volume 15 ml/kg of body weight; fraction ofinspired oxygen (Fio2) = 0.5 mixed with nitrogenous-protoxide (N2 02); pulmonary end-expiratory pressure (PEEP) = 5 cm H20; respiratory rate between 12 and 15 rpm maintaining the partial pressure ofarterial carbon dioxide (Paco2) at 32-35 mm Hg.
An indwelling catheter was inserted into the femoral artery for blood pressure monitoring and blood sampling. A triple-lumen thermodilution Swan-Ganz catheter (Edwards Laboratories AHS, Afiasco, Puerto Rico) was introduced through an upper limb vein and advanced into a main pulmonary artery. Both the Swan-Ganz and the arterial catheters were connected to pressure transducers (model 21080A, Hewlett-Packard Co., Palo Alto, CA) previously leveled with the right atrium. Pressure measurements and electrocardiogram were recorded using a four-channel amplifier (model 7754B, Hewlett Packard Co.).
Cardiac output (CO) was measured by the thermodilution technique (cardiac output computer model 9520, Edwards Laboratories); each value was the mean of three consecutive determinations.
Study protocol. The dogs were divided into two groups: (a) a control group (n = 8), in which Escherichia coli endotoxin (2 mg/kg) was infused intravenously during a 10-min period, (E. coli acetone powder, serotype 026:B6 strain ATCC 12795, Sigma Chemical Co., St Louis, USA); (b) an experimental group (n = 8), which received E. coli endotoxin as in the control group and an i.v. injection ofthe contact system inhibitor, C1-INH (500 IU) (Behring Institute, Marburg, FRG). The C I -INH was administered 30 min before the infusion of E. coli endotoxin.
The following hemodynamic parameters were measured immediately before and at 60, 120, and 180 min after the administration ofthe endotoxin: arterial pressure (AP), heart rate (HR), pulmonary arterial pressure (PAP), central venous pressure (CVP), pulmonary capillary wedge pressure (PCWP), CO, partial pressure ofarterial oxygen Pao2, Paco2, partial pressure of mixed venous blood oxygen (Pvo2), arterial oxygen saturation (SATao2), mixed venous blood oxygen saturation (SATvo2), and hemoglobin.
The following hemodynamic and pulmonary function parameters were calculated based on previously published formulas (36, 37) : mean arterial pressure (MAP), mean pulmonary arterial pressure (MPAP), cardiac index (CI), systolic index (SI), left ventricular systolic work index (LVSWI), right ventricular systolic work index (RVSWI), systemic vascular resistance index (SVRI), pulmonary vascular resistance index (PVRI), alveolo-arterial oxygen difference (AaDco2), arterio-venous oxygen difference (a-vDco2), intrapulmonary shunt (Qs/Qt%), oxygen consumption (Vo2), and°2 delivery (02-Deliv). Body surface area (BSA) was calculated using the formula, BSA = 0.112 x 3 V(weight)2 (38) .
Blood samples were obtained at the same time interval for evaluation of blood contact phase, complement systems, and cell count.
Bloodgases. Pao2, Paco2, and pH were measured with a blood gas analyzer (Radiometer, BM-S2, Copenhagen, DK).
Hemoglobin levels, SATao2 and SATvo2 were measured by an oximeter (OSM 2, Hemoximeter, Radiometer). Mixed venous blood samples were collected from the distal portion of the Swan-Ganz catheter.
Sampling procedures and assays. Blood samples were obtained from the proximal lumen of the Swan-Ganz catheter and placed into plastic tubes containing either 3.8% sodium citrate or EDTA. Plateletpoor plasma was obtained from blood samples centrifuged for 15 min at 2,500 g. All samples were stored at -70'C until the day ofthe assay.
Routine coagulation tests were performed using standard methods (39) . The coagulant activity of factors XII and XI was measured by a one-stage assay based on the partial thromboplastin time using as substrate factor XII-and XI-deficient plasma (39) . Plasma PK levels were measured by the method ofGallimore et al. (40) , using S-2302 as substrate and a PK activator (AB Kabi Diagnostica, Stockholm, Sweden); before activation, platelet-poor plasma was incubated with acetone at 0C for 15 min; the activation with PK activator was maintained for a period of 5 min.
The changes in CI-INH activity and plasma concentration of Cl-INH antigen were assessed in two additional dogs of each group. Plasma levels ofCI inhibitor antigen in blood samples were estimated using rocket immunoelectrophoresis (41) . Briefly, a 1% (wt/vol) agarose over gel Bond film with 37.5 mM Tris, 100 mM glycine (pH 8.6) for both gel and electrophoresis buffer, and 3% human Cl inhibitor antiserum (Behringwerke, Marburg, FRG). Incubation lasted 12 h at 10 V/cm, then it was cooled with tap water. Human Cl inhibitor was used as reference to estimate the amount ofC I inhibitor in the experimental blood sample. After electrophoresis, the plates were maintained for 3 d in a Petri dish with 0.9% NaCl to eliminate nonreacting proteins. The endotoxin-treated dog plasma was supplemented with human Cl inhibitor to increase the precipitin lines against Cl inhibitor antibodies (42).
The activity of Cl-INH was measured by an amidolytic method (kit from Immuno SA Laboratory, Barcelona, Spain) using an excess of C,-esterase and C2HjCo-Lys(E-Cbo)-Gly-Arg-pNa as substrate.
The fraction C3c ofcomplement was also determined by electroimmunodiffusion (41), using a dog C3c antiserum (Nordic Immunochemical Laboratory, Tilburg, The Netherlands).
Statistical methods. The results are expressed as the mean±SE of the absolute values and the percent change from baseline. Comparisons between means were made by ANOVA followed by test of Sheffee for multiple comparison. Statistical significance was defined as a P < 0.05.
Results
Systemic and pulmonary hemodynamics. Baseline hemodynamic parameters from both groups are presented in Table I .
The percent changes in MAP, PCWP, MPAP, and CVP are summarized in Fig. 1 . In both groups, the MAP decreased progressively throughout the experimental period. The decrement in MAP was similar in both groups. In the control group, the MAP decreased from 125±5 to 81±4 mm Hg at 180 min, and in the C1-INH group from 129±6 to 85±4 mm Hg. The fall in MAP occurred despite no change in cardiac filling pressures (CVP and PCWP). In contrast, in both groups, the MPAP remained unchanged during the study period.
Ventricular function. Changes in HR, CI, SI, LVSWI, RVSWI, SVRI, and PVRI are expressed in Table II and Fig. 2 . Basal values were similar in both groups (Table I ). The CI and SI decreased in both groups while HR remained unchanged. The decline in CI and SI was associated with a concomitant decrease in LVSWI and RVSVI. The degree of decrease in parameters reflecting ventricular function was not the same in both groups. Whereas in the control group CI, LVSWI, and RVSWI decreased progressively throughout the experiment, in (Fig. 3) . The decrease in Pao2 observed in the control group was associated with an increase in A-aDo2 and Qs/Qt%. No change in these parameters was observed in the C I -INH group (Fig. 3 ).
In the control group, both Vo2 and 02 Deliv. decreased significantly at 180 and 120 min, respectively (Table III) decrease coincided with the a marked fall in CI. By contrast, no significant change was observed in Vo2 and 02 Deliv. in the Cl-INH group. Hematologic parameters. Fig. 4 shows the changes in blood levels of factors XII and XI, PK, and C3c during the study period. The infusion of E. coli to the control dogs produced a decrease in blood levels of factors XII and XI. Similar results were observed in the Cl-INH group despite the inhibition of the contact system.
In control dogs, the blood levels of PK decreased progressively throughout the study period. The administration of CI-INH prevented the fall in PK. A decrease in C3c levels was observed in both groups. However, at 180 min, the decrease in C3c was more pronounced in control dogs than in those receiving Cl-INH. During the 3 h ofthe experiment, polymorphonuclear cell count decreased in both groups from 5.5±0.4 X I09/ liter to 2.8±0.1 x 109/liter (P < 0.01 ) in the controls and from 6.8±0.4 X 109/liter to 2.3±0.1 X 109/liter (P < 0.01) in the 
Discussion
This study shows that an inhibition of the contact system by administration of C I-INH prevents the hypoxemia associated with experimentally induced endotoxic shock.
In dogs, the administration of E. coli endotoxin with or without C I -INH produced hypodynamic shock. The hypotenFactor XlI 11 * ** sion was associated with a decrease in CI and SI. This was explained by a decline in LVSWI and RVSWI, which occurred despite no change in cardiac filling pressures. The production of hypodynamic shock suggests a deterioration in cardiac function induced by endotoxin which has been previously described in both animal models and humans (8) (9) (10) (11) (12) . In both control and C I -INH groups, this hypodynamic state was associated with an increase in a-vDco2 and a decrease in serum bicarbonate (data not shown).
Whereas in control animals the Pao2 decreased, this parameter remained unchanged in dogs receiving C 1-INH. Thus, the inhibition of the contact system prevents to some extent the alteration in pulmonary function induced by E. coli endotoxin. The decrease in Pao2 produced by E. coli endotoxin administration is likely due to the increase in A-aDo2 and Qs/Qt% and the decrease in Vo2 and 02 Deliv. These results suggest that, in our model, endotoxin administration produced the ventilation/perfusion mismatch described in early phases of ARDS (24) . The inhibition ofthe contact system by administration of Cl -INH (Fig. 5) prevented the increase in A-aDo2 and Qs/ Qt%, and the decrease in Vo2 and 02-Deliv. These data suggest that the ventilation/perfusion mismatch seen in ARDS is in part due to an activation ofcontact system. A possible interpretation for the hypoxemia observed in our model is a change in airway function induced by endotoxemia. Owing to the anatomical characteristics of the trachea and the bronchial tree in the dog, differences between dynamic and static thoracopulmonary compliance are difficult to measure; thus, small differences in airway pressure (< 2 cm H20) due to endotoxin may have not been detected. Nevertheless, the differences observed in Pao2 between the control and Cl-INH groups are more likely attributable to an effect on the alveolocapillary exchange than to a change in airway function.
In our control dogs the alteration in pulmonary function was associated with an activation of the contact system as evidenced by a decrease in PK, factor XII, C I -INH, factor XI, and C3c (Figs. 4 and 5) . This decrease could not be attributed to hemodilution in that the hematocrit increased moderately during the experiment and the increase was similar in both groups (data not shown). Previous studies by us and others have shown that, in ARDS patients, the plasma levels of HK, factor XII, and PK were decreased suggesting an activation of the kallikrein-kinin system (29, 30) . In our study (29) , the decrease in PK levels correlated with the severity of the pulmonary dysfunction; conversely, in patients with pulmonary dysfunction due to cardiogenic pulmonary edema without ARDS, the plasma levels of PK, factor XII, and high molecular weight kininogen were not decreased. Thus, it appears that in ARDS the activation ofthe contact system is not a direct consequence of the pulmonary edema (3 1 ).
Carlson et al. (43) and Mcguire et al. (44) have estimated that the activation of the kallikrein-kinin system is the most important factor leading to ARDS. The study of Colman (45) suggested that during the activation of the blood coagulation system, Hageman factor undergoes contact activation with PK in the presence ofa cofactor, high molecular weight kininogen, and a negatively charged surface. This originates in the formation ofa serine protease, kallikrein. Subsequently, the high molecular weight kininogen releases bradykinin, the final product of the kallikrein-kinin system activation (46) . This vasoactive peptide would induce pulmonary damage resulting in an increase in vascular permeability and interstitial edema (44) . An activation of PK would also cause the release of elastase by neutrophils (47). Elastase then can produce tissue damage favoring ARDS. In the present study, the administration ofendotoxin produced a significant decrease in number of neutrophils, however a direct measurement of cell activation is not available. In addition, endotoxin administration produces an activation of the complement system (48, 49) ; in our dogs, this activation was suggested by the decrease in C3c. Complement activation leads to deposition of terminal complement proteins C5b-9 on platelets and endothelial cells, with subsequent cellular activation and expression of GMP-140 (50, 51 ) . Subsequently, the activation ofGMP-140 induces adhesion and activation of neutrophils creating a vicious circle of activation-induced activation (52) . The administration of Cl -INH may halt this vicious circle by preventing the activation of complement. This has been suggested by previous studies in rabbits (34) and pigs (35) .
The PVRI increased significantly in the control group. This has been attributed to multiple hemodynamic changes including the release of vasoactive peptides during endotoxic shock (53) . In dogs pretreated with Cl-INH, the PVRI did not increase significantly; this may have been the result ofthe inhibition ofthe contact system which could have partially prevented endothelial damage. The observed decrease in RVSWI in the control group may be explained by a negative inotropic effect of endotoxin (11, 12); in dogs receiving CI-INH the decrement in RVSWI was not as marked as in controls, a better oxygenation may have ameliorated the negative inotropic effect of endotoxin.
Finally, the worse hemodynamic conditions observed in the control group may be responsible for the decrease in Vo2 and in 02-Deliv, resulting in less 02 supply to the tissues.
In summary, the administration of E. coli endotoxin induces hypodynamic shock and a decrease in Pao2. This is associated with an increase in PVRI and an activation of the contact system. The inhibition ofthe contact system by administration ofC1-INH in addition to E. co/i endotoxin, prevented the decrease in Pao2 and the increase in PVRI. In conclusion, it is likely that hypoxemia induced by endotoxic shock is mediated by an activation of the contact system.
